ER-DRI is a potent peptide inhibitor that targets EV-A71. It directly binds to 3A and specifically neutralizes the activity of RNAi virus suppressor factors, thereby unlocking the antiviral RNAi response inhibited by 3A. ER-DRI also effectively inhibits another RNAi-dependent enterovirus, Coxsackievirus A16.
Molekulargewicht:
2818.23
Formel:
C118H201N49O30S
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
